(NASDAQ: NAGE) Niagen Bioscience's forecast annual revenue growth rate of 15.5% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 222.03%, and while it is forecast to beat the US market's average forecast revenue growth rate of 11.61%.
Niagen Bioscience's revenue in 2025 is $116,303,000.On average, 2 Wall Street analysts forecast NAGE's revenue for 2025 to be $10,012,983,751, with the lowest NAGE revenue forecast at $10,008,996,104, and the highest NAGE revenue forecast at $10,016,971,399. On average, 2 Wall Street analysts forecast NAGE's revenue for 2026 to be $12,385,634,222, with the lowest NAGE revenue forecast at $12,170,301,238, and the highest NAGE revenue forecast at $12,600,967,206.
In 2027, NAGE is forecast to generate $14,714,420,567 in revenue, with the lowest revenue forecast at $14,714,420,567 and the highest revenue forecast at $14,714,420,567.